E-Prescription Market Size, Share, Growth Analysis, By Product(Solutions, Services), By Delivery Mode(Cloud based, Premises based.), By End Use(Hospital, office Based physician, pharmacy), By Prescription Type(Controlled substance and Non controlled substance), By Region - Industry Forecast 2024-2031

North America dominated the market in 2021, owing to the healthcare industry’s growing digitalization, favourable government policies, and a flexible regulatory environment. Regional expansion will also be aided in the predicted period by rising private and public investment for the implementation of integrated EHRs. For instance, the Cooperative Agreement Notice of Funding Opportunity was published by the Office of the National Coordinator for Health Information Technology (ONC) (NOFO). This program’s goal is to make it possible for the technical standards required to achieve interoperability among healthcare IT systems to advance.

Europe region is expected to grow at fastest CAGR during the forecast period. Due to the stringent regulations in place in European nations to prevent medical mistakes. Furthermore, it is envisaged that EU measures will promote growth. The EU released a circular enabling use of an e-prescription given by a practitioner in a different nation while visiting a pharmacy in another EU country, despite the fact that many countries do not recognise e-prescriptions from other countries. Additionally, effective national government initiatives, like incentive programmes and strict laws against handwritten prescriptions due to the likelihood of medical errors, are the main factors driving the expansion of the market.